CBCS is engaged in the SciLifeLab National COVID-19 Research Program "Drug discovery and repurposing of drugs" with making available A high-quality drug repurposing set for COVID-19 related research.
CBCS Director Anna-Lena Gustavsson, has together with Drug has Discovery & Development Director Kristian Sandberg been appointed as scientific leaders for the "Drug discovery and repurposing of drugs" program.
The National program against COVID-19 are kindly sponsored both by SciLifeLab and Knut och Alice Wallenbergs Stiftelse and comprises 67 projects over 9 research areas..
For more information, please go to the Scilifelab webpage.